China Shineway Pharmaceutical Group's EBIT per Share for the
six
months ended in Dec. 2025 was $1.86.
Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 was $4.74.
During the past 12 months, the average EBIT per Share Growth Rate of China Shineway Pharmaceutical Group was -11.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -0.60% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 10.30% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 5.30% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
CSWYY'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -19.8 Med: 4.2 Max: 43.7
Current: -0.6
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of China Shineway Pharmaceutical Group was 43.70% per year. The lowest was -19.80% per year. And the median was 4.20% per year.
CSWYY's 3-Year EBIT Growth Rate is ranked worse than 63.12% of 808
companies
in the Drug Manufacturers industry
Industry Median: 7.65
vs CSWYY: -0.60
China Shineway Pharmaceutical Group (OTCPK:CSWYY) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
China Shineway Pharmaceutical Group EBIT per Share Related Terms
China Shineway Pharmaceutical Group EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group EBIT per Share Chart
EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $4.74
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Shineway Pharmaceutical Group (CSWYY) has a EBIT per Share of $4.74 as of Dec. 2025. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on China Shineway Pharmaceutical Group and its competitors. According to the industry distribution chart, China Shineway Pharmaceutical Group ranks #510 out of 808 companies in the Drug Manufacturers industry, placing it in the top 63.1%.
Is China Shineway Pharmaceutical Group's EBIT per Share too high?
China Shineway Pharmaceutical Group's current EBIT per Share is $4.74. The Drug Manufacturers industry median EBIT per Share is 7.65. China Shineway Pharmaceutical Group's value of $4.74 is 38% below this industry median. Based on the distribution chart, China Shineway Pharmaceutical Group ranks #510 out of 808 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, China Shineway Pharmaceutical Group has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does China Shineway Pharmaceutical Group's EBIT per Share compare to ZTS?
According to the Drug Manufacturers industry distribution chart, China Shineway Pharmaceutical Group ranks #510 out of 808 companies for EBIT per Share. This places China Shineway Pharmaceutical Group in the lower half of its industry. The industry median EBIT per Share is 7.65. China Shineway Pharmaceutical Group's value of $4.74 is 38% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Drug Manufacturers company?
The median EBIT per Share among Drug Manufacturers companies is 7.65, based on 808 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. China Shineway Pharmaceutical Group's current EBIT per Share of $4.74 is 38% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on China Shineway Pharmaceutical Group and its competitors. For the Drug Manufacturers industry, the median EBIT per Share is 7.65 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. China Shineway Pharmaceutical Group's current EBIT per Share is $4.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is China Shineway Pharmaceutical Group stock overvalued right now?
China Shineway Pharmaceutical Group (CSWYY) has a current EBIT per Share of $4.74. The stock's GF Value™ is $17.28, compared to a current price of $19.25 — trading 11.4% above its estimated fair value. The current EBIT per Share is $4.74 and 38% below the Drug Manufacturers industry median of 7.65. China Shineway Pharmaceutical Group's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For China Shineway Pharmaceutical Group (CSWYY), the current EBIT per Share is $4.74 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is China Shineway Pharmaceutical Group (CSWYY) Overvalued in 2026?
Based on GuruFocus' analysis, China Shineway Pharmaceutical Group stock appears to be overvalued.
The current stock price of $19.25 is trading 11.4% above its estimated GF Value™ of $17.28.
Key valuation signals for CSWYY:
EBIT per Share: $4.74
GF Value™: $17.28 vs. price of $19.25 (11.4% above fair value)
Industry Position: 38% below the Drug Manufacturers median (#510 of 808)
No single metric tells the full story. See the CSWYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
China Shineway Pharmaceutical Group Business Description
China Shineway Pharmaceutical Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in the research, development, manufacturing, and trading of modern Chinese medicines. The company's products comprise injection, soft capsule, granule, traditional Chinese medicine formula granules, and others, of which injections generate maximum revenue for the company. Geographically, the group operates in the People's Republic of China (PRC) and Hong Kong.
92GF Score
Get the complete analysis for CSWYY
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CSWYY has been successfully added to your 
